Deployment of Ultrafiltration for Concentrating and Purification of Antigens
https://doi.org/10.21055/0370-1069-2015-1-79-84
Abstract
Represented is domestic and foreign literature review dedicated to usage of ultrafiltration for concentrating and purification of antigens. Discussed are the issues of deployment of various ultrafiltration techniques. It is determined that filtering in the tangential mode by means of modules with flat-frame filtering elements is among the prospective ones. Demonstrated is the impact of such technological specifications as concentration rate, pressure, temperature, and membrane nominal cut-off on molecular mass on the quality of target products, the time elapsed, and preparation losses decrease (increase). Literature data analysis proves to be useful for the selection of the proper procedure for concentrating and purification of protective antigens of bacterial and viral origins. In addition, it allows for taking into account the parameters under discussion when developing specific manufacturing technologies for diagnostic and preventive medical immunobiological preparation production.
About the Authors
A. V. Komissarov
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
Yu. A. Aleshina
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
O. V. Gromova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
A. K. Nikiforov
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
S. A. Eremin
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
O. A. Volokh
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
O. A. Lobovikova
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
A. I. Perepelitsa
Russian Research Anti-Plague Institute “Microbe”
Russian Federation
Russian Federation
References
1. Agafonov A.P., Strel’tsova M.A., Ignat’ev G.M., Tverdokhlebov A.V., Chepurnov A.A., Kaliberov S.A., Kuz’min V.A., Cherny N.B. [Method for the production of concentrates from the viruses inducing hemorrhagic fevers and possessing immunogenic and protective activity]. RF Patent 2029561, 27.02.1995.
2. Biryukov V.V. [Fundamental Principles of Industrial Biotechnology]. M.; 2004. 296 p.
3. Borkovski A. [Multiple vaccination including Neisseria meningitides serogroup C]. RF Patent 2457858, 10.08.2012.
4. Brakht K., Katalevsky E.E., Savel’eva S.P. [Cross-flow filtration]. Farmatsevt. Tekhnol. Upakovka. 2009; 6:47–51.
5. Brok T. [Membrane Filtration]. M.: Mir; 1987. 462 p.
6. Byvalov A.A., Evstigneev V.I., Darmov I.V., Pimenov E.V. [Antigen composition of chemical plague vaccine]. RF Patent 2190424, 10.10.2002.
7. Byvalov A.A., Evstigneev V.I., Darmov I.V., Pimenov E.V. [Identification and isolation of the antigen, protecting guinea pigs from experimental plague infection]. Probl. Osobo Opasn. Infek. 2005; 1(89):54–8.
8. Generalov S.V., Abramova E.G., Matveeva Zh.V., Zhulidov I.M., Lobovikova O.A., Savitskaya L.V., Minaeva L.N., Galkina M.V., Mikheeva T.A., Komissarov A.V., Kireev M.N., Nikiforov A.K. [Production of rabbit anti-rabies immunoglobulin using cultural antigen]. Probl. Osobo Opasn. Infek. 2012; 2(112):78–81.
9. Gromova O.V., Dzhaparidze M.N., Dyatlov I.A., Kireev M.N., Fedorova V.A., Alenkina T.V., Abramova E.G. [New method for the production of purified cholera O-antigen with a view to obtain cholera diagnostic preparations]. Biotekhnologia. 2002; 2:42–6.
10. Gromova O.V., Nizhegorodtsev S.A., Dyatlov I.A., Kutyrev V.V. [Optimization of the process of cholera chemical pelleted vaccine production using ultrafiltration technology]. Probl. Osobo Opasn. Infek. 2011; 109:71–4. 11. Dzhayappa Kh., O’Konnell K. [Vaccine ALFA TAXOIDA C. perfringens]. RF Patent 2434638, 27.11.2011.
11. Dyatlov I.A., Nizhegorodtsev S.A., Gromova O.V., Vasin Yu.G., Butov A.S., Klokova O.D., Belyakova N.I. [Development of ultrafiltration technology for the production of cholera vibrio O-antigen with a view to vaccine manufacturing]. Probl. Osobo Opasn. Infek. 2001; 2(82):133–9.
12. Egorova N.B., Semenov B.F., Kurbatova E.A., Efremova V.N., Kaverina K.G., Mikhailova N.A. [Poly-component vaccine for immune-prophylaxis and immuno-therapy of the diseases caused by opportunistic (potentially) pathogenic microorganisms]. RF Patent 2209081, 27.07.2003.
13. Yeremin S.A., Volokh O.A., Shepelev I.A., Dalvadyants S.M., Dyatlov I.A. [Designation of new technological patterns and ranging the processes of deriving the antigens from the plague and tularemia microbial agents]. Probl. Osobo Opasn. Infek. 2006; 2(92):58–61.
14. Ignatov P.E., Fedorov A.I. [Method for the production of protective extracellular antigen of Brucella, which can induce chronic brucellosis]. RF Patent 2199340, 27.02.2003.
15. Il’chenko T.E., Bilalova G.P., Stavitskaya N.Kh., Solyanik R.G., Bystritsky L.D., Krasil’nikov I.V. [Vaccine “ENCEVIR” – state-of-the-art medical preparation for tick-borne encephalitis prophylaxis]. Sibir. Med. Zh. 2009; 2(2): 50–5.
16. Karavaev Yu.D., Semenova I.N., Mel’nik N.V., Plokhova A.A. [Method for the production of the vaccine for animal necrobacillosis prevention and treatment]. RF Patent 2329828, 27.07.2008.
17. Kisilevsky M.V., Donenko F.V., Voyushin K.E., Trishin A.V., Kurbatova E.A., Egorova N.B., Gruber I.M., Akhmatova N.K., Semenova I.B., Semenov B.F. [Method for the production of protective protein-bearing fraction of bacteria]. RF Patent 2311197, 27.11.2007.
18. Kozlov V.E., Nichveeva L.D., Grechkina N.T., Shevyrev N.S., Azarova N.A., Sharov A.N., Bezgin V.M., Solodov E.N., Bukova N.K. [Method for the production of tuberculin]. RF Patent 2113233, 20.06.1998.
19. Komissarov A.V., Eremin S.A., Ul`yanov A.Yu., Aleshina Yu.A., Nikiforov A.K., Vasin Yu.G., Klokova O.D., Belyakova N.I. [Development of the experimental technology for protective antigens of Vibrio cholerae 569B Inaba concentration by means of tangential ultrafiltration]. Probl. Osobo Opasn. Infek. 2011; 3(109):75–7.
20. Komissarov A.V., Eremin S.A., Aleshina Yu.A., Vasin Yu.G., Klokova O.D., Beliakova N.I. [Experimental evaluation of application of “cross-flow” ultrafiltration method for O-antigen concentrating in cholera chemical bivalent vaccine production]. Probl. Osobo Opasn. Infek. 2011; 2(108):83–6.
21. Mikhailova N.A., Shaimukhametov F.A., Kuznetsova T.N. [Method for the production of A Pseudomonas aeruginosa exotoxin]. RF Patent 1596770, 09.06.1995.
22. Neschislyaev V.A., Molokhova E.I., Chistokhina L.P., Sorokina Yu.V., Belova I.V. [Multiple use of biologically active metabolites of Lacto- and Bifidobacteria in probiotics manufacturing]. Vestnik Biotekhnol. Fizikokhim. Biol. imeni Y.A.Ovchinnikova. 2006; 2(4):29–30.
23. Nyn’I.V. [Biotechnology as a basic approach to manufacturing of immunobiological preventive preparations]. Vestnik Biotekhnol. Fizikokhim. Biol. imeni Y.A.Ovchinnikova. 2006; 2(4):62–3.
24. Sitnik N.P., Zagidullin N.V., Israfilov A.G., Enikeeva L.F., Mukhacheva A.V., Shafeeva R.S., Kuntsevich Yu.G., Petrova I.I. [Method for the production of highly specific heterologous anti-rabies serum]. RF Patent 2322503, 20.04.2008.
25. Sit’kov V.I., Surmilo A.P., Lemeshko V.N., Soboleva G.L., Panin A.N. [Method for the production of polyvalent vaccine against animal leptospirosis]. RF Patent 2096042, 20.11.1997.
26. Scopus R. [Methods of Protein Purification]. M.: Mir; 1985. 237 p.
27. Stroganov V.V., Kosmaenko O.M., Popov A.A., Nikitina G.P., Dzhaparidze M.N., Kotkina T.A. [Application of ultrafiltration performed on the home-produced semi-permeable membranes UAM for separation of somatic O-antigen from cholera vibrio exotoxin]. Probl. Osobo Opasn. Infek. 1978; 4(68):50–67.
28. Stroganov V.V., Kosmaenko O.M., Tikhonov N.G., Adamov A.K., Vasin Yu.G., Nikitina G.P., Matorina N.A. [Experimental studies of ultrafiltration module for manufacturing purified cholera exotoxin]. In: [Prophylaxis of Particularly Dangerous Infections]. 1980. P. 50–67.
29. Tkachenko E.A., Dzagurova T.K., Nabatnikov P.A., Mikhailov M.I. [Method for the production of the mixed bivalent, cultural, inactivated, concentrated, purified vaccine for HFRS (hemorrhagic fever with renal syndrome) prophylaxis]. RF Patent 2445117, 20.03.2012.
30. Cherkasov A.N., Pasechnik V.A. [Membranes and Sorbents in Biotechnology]. L.: Khimiya; 1991. 239 p.
31. Shevtsov A.N., Lobastov V.S., Borovskoy D.V., Menovshchikov V.A., Khapaev N.G. [Method for the production of anthrax protective antigen]. RF Patent 2340356, 10.12.2008.
32. Shevyrev N.S., Bezgin V.M., Kozlov V.E., Nichveeva L.D., Solodov E.N., Sharov A.N., Bukova N.K., Tyrina V.S. [Allergen for diagnostics of tuberculosis and method for its production]. RF Patent 2045959, 20.10.1995.
33. Shevyrev N.S., Bezgin V.M., Nichveeva L.D., Kozlov V.E., Solodov E.N., Grinev A.A., Sorokina A.A., Alekhin V.A., Sharov A.N., Tyrina V.S., Bukova N.K. [Method for the production of tuberculin]. RF Patent 2035914, 27.05.1995.
34. Shepelev I.A., Eremin S.A., Vasin Yu.G., Volokh O.A., Alenkina T.V., Belyakova N.I., Kuznetsova E.M., Nikiforov A.K. [Prospects for application of ultrafiltration technology for the scaled preparation of plague microbe and cholera vibrio major antigens]. Probl. Osobo Opasn. Infek. 2011; 3(109):84–7.
35. Shepelev I.A., Volokh O.A., Yereomin S.A., Dyatlov I.A. [Optimization of the techniques for deriving the protective “C” complex of the tularemia pathogen]. Probl. Osobo Opasn. Infek. 2006; 2(92):61–4.
36. El’bert L.B., Krasil’nikov I.V., Drozdov S.G., Terletskaya E.N., Timofeev A.V. [Concentrated purified vaccine against tick-borne encephalitis produced using ultrafiltration and chromatography]. Vopr. Virusol. 1985; 1:90–3.
37. Arockiasamy A., Krishnaswamy S. Purification of integral outer-membrane protein OmpC, a surface antigen from Salmonella typhi for structure-function studies: a method applicable to enterobacterial major outermembrane protein. Anal. Biochem. 2000; 283(1):64–70.
38. Barrett P., Mundt W., Kistner O., Howard M. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert. Rev. Vaccines. 2009; 8:607–18.
39. Jang H., Hyo S.K., Jeong A.K. Improved Purification Process for Cholera Toxin and its Application to the Quantification of Residual Toxin in Cholera Vaccines. J. Microbiol. Biotechnol. 2009; 19(1):108–12.
40. Takagi M., Barbosa R. Purification of capsular polysaccharide produced by Haemophilus influenzae type b through a simple, efficient and suitable method for scale-up. Appl. Microbiol. Biotechnol. 2008; 35:1217–22.
41. Zydney A.L., Kuriyel R. Protein concentration and buffer exchange using ultrafiltration. Methods in Biotechnology. 2000; 9:35–46.
Review
For citations:
Komissarov A.V., Aleshina Yu.A., Gromova O.V., Nikiforov A.K., Eremin S.A., Volokh O.A., Lobovikova O.A., Perepelitsa A.I. Deployment of Ultrafiltration for Concentrating and Purification of Antigens. Problems of Particularly Dangerous Infections. 2015;(1):79-84. (In Russ.) https://doi.org/10.21055/0370-1069-2015-1-79-84
Views:
939
Email this article 